MedTrace Logo

An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid Autoimmunity

NCT04943146 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 402

Last updated 2021-06-29

No results posted yet for this study

Summary

Thyroid autoimmunity(TAI) per se have adverse effect on pregnancy outcomes，and aspirin and prednisone were used frequently in antithyroid antibodies(ATA) positive infertile women in clinical practice, but the impact of these medicines is still controversial. Therefore, aim of the study was to investigate whether or not the treatment of prednisone in addition to aspirin was capable of improving reproductive outcomes in euthyroid infertile women.

Conditions

  • Thyroid Diseases

Interventions

DRUG

Prednisone 10 MG+aspirin 100MG

Discontinue medication based on early pregnancy outcome

Sponsors & Collaborators

  • Ningbo Women & Children's Hospital

    collaborator OTHER

  • People's Hospital of Jinhua

    collaborator UNKNOWN

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-06-30
Completion
2022-03-31
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943146 on ClinicalTrials.gov